These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4010694)

  • 21. Frequency of HPRT gene mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine corresponds to replication error phenotypes of cell lines.
    Zhu W; Yamasaki H; Mironov N
    Mutat Res; 1998 Feb; 398(1-2):93-9. PubMed ID: 9626969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity and mutational spectrum of N-methyl-N'-nitro-N-nitrosoguanidine in the hprt gene in G1-S and late S phase of diploid human fibroblasts.
    Yang JL; Lin JG; Hu MC; Wu CW
    Cancer Res; 1993 Jun; 53(12):2865-73. PubMed ID: 8504428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in the granuloma pouch assay.
    Radermacher J; Thorne GM; Goldin BR; Sullivan CE; Gorbach SL
    Mutat Res; 1987 Feb; 187(2):99-103. PubMed ID: 3807940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of hprt gene mutations in splenic T-lymphocytes from the rat exposed in vivo to DNA methylating agents is correlated with formation of O6-methylguanine in bone marrow and not in the spleen.
    Jansen JG; de Groot AJ; van Teijlingen CM; Tates AD; Vrieling H; van Zeeland AA
    Carcinogenesis; 1996 Oct; 17(10):2183-91. PubMed ID: 8895487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A procedure for the CHO/HGPRT mutation assay involving treatment of cells in suspension culture and selection of mutants in soft-agar.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1987 Apr; 182(2):99-111. PubMed ID: 3561430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structural basis for the mutagenicity of aristolochic acid.
    Pfau W; Pool-Zobel BL; von der Lieth CW; Wiessler M
    Cancer Lett; 1990 Nov; 55(1):7-11. PubMed ID: 2245413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granuloma pouch assay. I. Induction of ouabain resistance by MNNG in vivo.
    Maier P; Manser P; Zbinden G
    Mutat Res; 1978 Oct; 54(2):159-65. PubMed ID: 362187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the mutagenic and cytostatic potential of aristolochic acid (3,4-methylenedioxy-8-methoxy-10-nitrophenanthrene-1-carboxylic acid) and several of its derivatives.
    Pezzuto JM; Swanson SM; Mar W; Che CT; Cordell GA; Fong HH
    Mutat Res; 1988 Dec; 206(4):447-54. PubMed ID: 3060719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenic activity of 3 diazoacetylglycine derivatives on V79 Chinese hamster cells.
    Pani B; Babudri N; Bartoli-Klugmann F; Venturini S; di Fant I
    Mutat Res; 1980 Aug; 78(4):375-9. PubMed ID: 6777694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic gpt+ V79 cell lines differ in their mutagenic response to clastogens.
    Klein CB; Su L; Rossman TG; Snow ET
    Mutat Res; 1994 Jan; 304(2):217-28. PubMed ID: 7506365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotoxic and antigenotoxic assessment of four newly synthesized dihydropyridine derivatives.
    Turhan K; Ozturkcan SA; Turgut Z; Karadayi M; Aslan A; Gulluce M
    Toxicol Ind Health; 2014 Apr; 30(3):275-83. PubMed ID: 22903173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver.
    Schmeiser HH; Pool BL; Wiessler M
    Carcinogenesis; 1986 Jan; 7(1):59-63. PubMed ID: 3510750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA adduct formation of aristolochic acid I and II in vitro and in vivo.
    Schmeiser HH; Schoepe KB; Wiessler M
    Carcinogenesis; 1988 Feb; 9(2):297-303. PubMed ID: 3338114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated dose liver and gastrointestinal tract micronucleus assays using N-methyl-N'-nitro-N-nitrosoguanidine in young adult rats.
    Takayanagi T; Wako Y; Kawasako K; Hori H; Fujii W; Ohyama W
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Mar; 780-781():100-6. PubMed ID: 25892628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased genetic stability of HeLa cells after connexin 43 gene transfection.
    Zhu W; Mironov N; Yamasaki H
    Cancer Res; 1997 Jun; 57(11):2148-50. PubMed ID: 9187113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of pine cone extract fraction VI with mutagens.
    Lee H; Aoki K; Sakagami H; Yoshida T; Kuroiwa Y
    Mutat Res; 1993 Jul; 297(1):53-60. PubMed ID: 7686273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifying role of vitamins on the mutagenic action of N-methyl-N'-nitro-N-nitrosoguanidine.
    Shetty TK; Francis AR; Bhattacharya RK
    Carcinogenesis; 1988 Aug; 9(8):1513-5. PubMed ID: 3402049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens.
    Saito J; Sakai Y; Nagase H
    Mutat Res; 2006 Oct; 609(1):68-73. PubMed ID: 16884943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the mutagenic effects of N-methyl-N'-nitro-N-nitrosoguanidine and 9-aminoacridine by indenopyridines in the Salmonella typhimurium tester strain 1537 and E. coli.
    Turhan K; Ozturkcan SA; Turgut Z; Karadayi M; Gulluce M
    Drug Chem Toxicol; 2014 Oct; 37(4):365-9. PubMed ID: 24341665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the mutagenic activity of 6 hepatotoxic pharmaceutical drugs in the Salmonella typhimurium microsome test, and the HGPRT and Na+/K+ ATPase system in cultured mammalian cells.
    Dayan J; Deguingand S; Truzman C
    Mutat Res; 1985 Jul; 157(1):1-12. PubMed ID: 2989681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.